To determine the role of the adaptive immune system in CTX-mediated antitumor effect in our lymphoma model, tumor-bearing mice were depleted of the endogenous CD4+ and CD8+ T cells before receiving CTX treatment (Figure 1B schema). This evidence concerns the gene CD4 and neoplasm.